Titre:
  • 211At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges
Auteur:Levillain, Hugo; Moës, Anne Royer; Gameiro-Paris, Cristiana; Abrunhosa, Antero; Deakin, Tom; Gebhart, Géraldine; Herth, Matthias Manfred; Gestin, Jean François; Haddad, Ferid; Jensen, Andreas Ingemann; Bue, Rebecca Lo; Mikolajczak, Renata; Otamendi, Adrian; Staunton-Mann, Katie; Tabury, Kevin; Flamen, Patrick; Seimbille, Yann; Primac, Irina; Neumaier, Bernhard; Pruszyński, Marek; Lacombe, Marie; Jensen, Holger; Humpert, Swen; Harray, Jérôme; Geets, Jean Michel; Garcia, Rocío; Guérard, François; Fouinneteau, Romain; Ferrer, Ludovic; Delbart, Wendy; Damas, Liliana; Chérel, Michel; Bourdeau, Cécile; Battisti, Umberto Maria
Informations sur la publication:European journal of nuclear medicine and molecular imaging
Statut de publication:Publié, 2026
Sujet CREF:Sciences biomédicales
Cancérologie
Mots-clés:ACCELERATE
Astatine-211
Clinical trials
Radiopharmacy
Self-imaging
Targeted alpha therapy
Theranostics
Note générale:SCOPUS: ed.j
Langue:Anglais
Identificateurs:urn:issn:1619-7070
info:doi/10.1007/s00259-026-07950-y
info:scp/105040760774
info:pmid/42209820